73 results
Pathophysiology of the Renin-angiotensin-aldosterone system (RAAS) and inhibitors

#Pathophysiology #Pharmacology #RAAS #Renin #Angiotensin #Aldosterone #System #ACEInhibitors
Pathophysiology ... system (RAAS) and ... inhibitors #Pathophysiology ... #Pharmacology #
Infographic depicting the main pearls of various types of congenital adrenal hyperplasia for the medical student.
#CAH #algorithm ... diagnosis #comparison #treatment ... #Peds #Endocrinology ... #Adrenal #pathophysiology
Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism.
Initial treatment ... renal bone disease and ... the first-line treatments ... inhibits PTH release ... #Pharmacology #Pathophysiology
â–º
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Dermatitis - Topical Treatment ... 20% of children and ... After non-pharmacologic ... skin locations and ... #Medications #Pharmacology
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Dermatitis - Topical Treatment ... therapy is non-pharmacologic ... the first line pharmacologic ... Dermatitis #Topical #Treatment ... #Medications #Pharmacology
HIV Antiretroviral Pharmacokinetic Boosters - Ritonavir & Cobicistat 

Ritonavir & Cobicistat are 2 pharmacokinetic boosters used
boosters used in HIV treatment ... are both CYP3A4 INHIBITORS ... metabolism of drugs and ... and a 3A4 inhibitor ... HIV #Boosters #Pharmacology
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
Xa Inhibitors - ... Oral Xa inhibitors ... patients with VTE treatment ... /ambcarerx #XaInhibitors ... Rivaroxaban #Dosing #Pharmacology
Treatment Options for Helicobacter Pylori and Peptic Ulcer Disease

Active Helicobacter pylori—associated ulcer
1. Treat with anti—H pylori
Treatment Options ... Helicobacter Pylori and ... Treatment options ... and 1—2 weeks after ... #Management #Pharmacology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... inactivates GLP-1 and ... #Pharmacology # ... DM2 #diabetes #endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... Mechanisms of Action: Inhibits ... #Pharmacology # ... DM2 #diabetes #endocrinology